Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015)

Penumbra's (PEN) quarterly Current Deferred Tax Assets came in at $7.3 million in Q3 2015, up 16.77% on a QoQ basis from $6.3 million in Q4 2014.

Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Penumbra (PEN) has 2 years of Current Deferred Tax Assets data on file, last reported at $7.3 million in Q3 2015.

On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $7.3 million in Q3 2015; TTM through Sep 2015 was $7.3 million, a N/A change from a year earlier, with the FY2014 full-year figure at $6.3 million, changed N/A from the prior year.
Current Deferred Tax Assets for Q3 2015 stood at $7.3 million, up from $6.3 million in the prior quarter.
Over the last five years, Current Deferred Tax Assets for PEN reached as high as $7.3 million in Q3 2015 and fell as low as $6.3 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Penumbra	12.48 Bn	11.87 Bn	253.41 Mn

Download Data